- Jessica Grossman 
- Susan L. Kelley
- William H. Rastetter
- Robin Steele
- Gregory Matz
- Cheryl Blanchard
Acquired Microchips Biotech in December 2019
"Microchips’ innovative drug delivery technology is designed to store and precisely deliver hundreds of therapeutic doses over months or years in a single implant. The implant is intended to be operated by the patient to deliver medication on demand or on a pre-determined schedule that can be activated or deactivated wirelessly, as required.
"With the support of the The Bill & Melinda Gates Foundation in the form of approximately $17.9 million in grant funding to date, and the potential for up to an additional $2.5 million in grant funding in 2020, Microchips has been developing an implantable long-acting, reversible contraceptive application of the technology."